These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 12093047)

  • 1. Echocardiography or Nt-proANP in post-myocardial infarction patients: is one enough?
    Pinto FJ
    Eur Heart J; 2002 Jul; 23(13):996-7. PubMed ID: 12093047
    [No Abstract]   [Full Text] [Related]  

  • 2. Prognostic value of two-dimensional echocardiography and N-terminal proatrial natriuretic peptide following an acute myocardial infarction. Assessment of baseline values (2-7 days) and changes at 3 months in patients with a preserved systolic function.
    Otterstad JE; St John Sutton MG; Froeland GS; Holme I; Skjaerpe T; Hall C
    Eur Heart J; 2002 Jul; 23(13):1011-20. PubMed ID: 12093053
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Correlation between serial changes in left-sided heart chambers and atrial natriuretic peptide and N-terminal pro atrial natriuretic peptide after a first myocardial infarction. An echocardiographic study.
    Svanegaard J; Johansen JB; Klitgaard NA; Thayssen P; Haghfelt T
    Scand Cardiovasc J; 1999; 33(6):355-61. PubMed ID: 10622548
    [TBL] [Abstract][Full Text] [Related]  

  • 4. N-terminal proatrial natriuretic peptide in primary care: relation to echocardiographic indices of cardiac function in mild to moderate cardiac disease.
    Hall C; Ihlen H; Bonarjee V; Dickstein K; Kjekshus J
    Int J Cardiol; 2003 Jun; 89(2-3):197-205. PubMed ID: 12767543
    [TBL] [Abstract][Full Text] [Related]  

  • 5. N-terminal proatrial natriuretic peptide predicts two-year remodelling in patients with acute transmural myocardial infarction.
    Hole T; Hall C; Skaerpe T
    Eur Heart J; 2004 Mar; 25(5):416-23. PubMed ID: 15033254
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neuroendocrine prediction of left ventricular function and heart failure after acute myocardial infarction. The Christchurch Cardioendocrine Research Group.
    Richards AM; Nicholls MG; Yandle TG; Ikram H; Espiner EA; Turner JG; Buttimore RC; Lainchbury JG; Elliott JM; Frampton C; Crozier IG; Smyth DW
    Heart; 1999 Feb; 81(2):114-20. PubMed ID: 9922344
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Plasma N-terminal B-Type natriuretic peptide as an indicator of long-term survival after acute myocardial infarction: comparison with plasma midregional pro-atrial natriuretic peptide: the LAMP (Leicester Acute Myocardial Infarction Peptide) study.
    Khan SQ; Dhillon O; Kelly D; Squire IB; Struck J; Quinn P; Morgenthaler NG; Bergmann A; Davies JE; Ng LL
    J Am Coll Cardiol; 2008 May; 51(19):1857-64. PubMed ID: 18466800
    [TBL] [Abstract][Full Text] [Related]  

  • 8. N-terminal proatrial natriuretic peptide correlates with systolic dysfunction and left ventricular filling pattern in patients with idiopathic dilated cardiomyopathy.
    Fruhwald FM; Fahrleitner A; Watzinger N; Dobnig H; Schumacher M; Maier R; Zweiker R; Leb G; Klein W
    Heart; 1999 Nov; 82(5):630-3. PubMed ID: 10525523
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Plasma N-terminal atrial natriuretic peptide in acute myocardial infarction.
    Kettunen RV; Leppäluoto J; Jounela A; Vuolteenaho O
    Am Heart J; 1994 Jun; 127(6):1449-55. PubMed ID: 8197967
    [TBL] [Abstract][Full Text] [Related]  

  • 10. N-terminal proBNP--the most cost effective way to identify post myocardial infarction left ventriular dysfunction?
    Struthers AD
    Eur Heart J; 2000 Sep; 21(18):1490-2. PubMed ID: 10973758
    [No Abstract]   [Full Text] [Related]  

  • 11. Natriuretic peptides in patients with diastolic dysfunction due to idiopathic dilated cardiomyopathy.
    Fruhwald FM; Fahrleitner A; Watzinger N; Fruhwald S; Dobnig H; Schumacher M; Maier R; Zweiker R; Klein WW
    Eur Heart J; 1999 Oct; 20(19):1415-23. PubMed ID: 10487802
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Usefulness of plasma N-terminal proatrial natriuretic peptide (proANP) as an early predictor of outcome in unstable angina pectoris or non-ST-elevation acute myocardial infarction.
    Jernberg T; Stridsberg M; Lindahl B
    Am J Cardiol; 2002 Jan; 89(1):64-6. PubMed ID: 11779526
    [No Abstract]   [Full Text] [Related]  

  • 13. Profile of plasma N-terminal proBNP following acute myocardial infarction; correlation with left ventricular systolic dysfunction.
    Talwar S; Squire IB; Downie PF; Mccullough AM; Campton MC; Davies JE; Barnett DB; Ng LL
    Eur Heart J; 2000 Sep; 21(18):1514-21. PubMed ID: 10973765
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Plasma proatrial natriuretic factor (1-98) concentration after myocardial infarction: relation to indices of cardiac and renal function.
    Bonarjee VV; Omland T; Nilsen DW; Caidahl K; Sundsfjord JA; Dickstein K
    Br Heart J; 1995 Jun; 73(6):511-6. PubMed ID: 7626348
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognosis in myocardial infarction patients with heart failure and normal or mildly impaired systolic function.
    Jarnert C; Edner M; Persson HE
    Int J Cardiol; 2007 Apr; 117(2):184-90. PubMed ID: 16860417
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Risk assessment in patients with unstable angina/non-ST-elevation myocardial infarction and normal N-terminal pro-brain natriuretic peptide levels by N-terminal pro-atrial natriuretic peptide.
    Jarai R; Iordanova N; Jarai R; Raffetseder A; Woloszczuk W; Gyöngyösi M; Geyer G; Wojta J; Huber K
    Eur Heart J; 2005 Feb; 26(3):250-6. PubMed ID: 15618049
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Midregional pro-atrial natriuretic peptide is a useful indicator for the detection of impaired left ventricular function in patients with coronary artery disease.
    Elmas E; Brueckmann M; Lang S; Kälsch T; Haghi D; Sueselbeck T; Dempfle CE; Borggrefe M
    Int J Cardiol; 2008 Aug; 128(2):244-9. PubMed ID: 17673312
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Plasma B-type natriuretic peptide reflects left ventricular hypertrophy and diastolic function in hypertension.
    Uusimaa P; Tokola H; Ylitalo A; Vuolteenaho O; Ruskoaho H; Risteli J; Linnaluoto M; Peuhkurinen K;
    Int J Cardiol; 2004 Nov; 97(2):251-6. PubMed ID: 15458692
    [TBL] [Abstract][Full Text] [Related]  

  • 19. N-terminal pro-atrial natriuretic peptide and exercise prescription in patients with myocardial infarction.
    Ikeda N; Yasu T; Nishikimi T; Nakamura T; Kubo N; Kawakami M; Momomura S; Saito M
    Regul Pept; 2007 Jun; 141(1-3):154-8. PubMed ID: 17292492
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Increased plasma levels of NT-proANP and NT-proBNP as markers of cardiac dysfunction in septic patients.
    Hoffmann U; Brueckmann M; Bertsch T; Wiessner M; Liebetrau C; Lang S; Haase KK; Borggrefe M; Huhle G
    Clin Lab; 2005; 51(7-8):373-9. PubMed ID: 16122147
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.